Access to innovative non-opioid medicines.
2025 · 4th Quarter (Oct 1 - Dec 31)
VERTEX PHARMACEUTICALS INCORPORATED
Filed by CGCN GROUP, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 21, 2026
- Income
- $80,000.00
- Expenses
- Not reported
- Registrant
- CGCN GROUP, LLC
- Filing UUID
- f5beca4f-9e32-4951-b980-62be3e234d53
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Access to innovative non-opioid medicines; Alternatives to PAIN, H.R. 1227; Alternatives to PAIN, S. 475.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.